Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
1378847 | Bioorganic & Medicinal Chemistry Letters | 2006 | 5 Pages |
A novel class of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as c-Jun-N-terminal kinase (JNK) inhibitors is described. These compounds were synthesized via the condensation of 2-nitrobenzaldehydes and hydroxypyrazoles. The structure–activity relationships (SAR) and kinase selectivity profile of the inhibitors are also discussed. Compound 16 was identified as a potent JNK inhibitor with good cellular potency.
Graphical abstractThis paper describes a novel class of 1,9-dihydro-9-hydroxypyrazolo[3,4-b]quinolin-4-ones as c-Jun-N-terminal kinase (JNK) inhibitors. These compounds were synthesized via the condensation of 2-nitrobenzaldehydes and hydroxylpyrazoles. The structure–activity relationships (SARs) and kinase selectivity profile of the inhibitors are also discussed. Compound 16 was identified as a potent JNK inhibitor with good cellular potency.Figure optionsDownload full-size imageDownload as PowerPoint slide